BTCYBIOTRICITY INC.

Nasdaq biotricity.com


$ 0.90 $ 0.06 (6.55 %)    

Thursday, 27-Jun-2024 15:47:24 EDT
QQQ $ 481.55 $ -1.85 (-0.38 %)
DIA $ 391.13 $ -1.91 (-0.49 %)
SPY $ 546.04 $ -1.60 (-0.29 %)
TLT $ 92.32 $ -1.41 (-1.5 %)
GLD $ 215.28 $ -0.66 (-0.31 %)
$ 0.927
$ 0.87
$ 0.00 x 0
$ 0.00 x 0
$ 0.87 - $ 0.93
$ 0.70 - $ 4.06
49,169
na
8.34M
$ 1.23
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 06-27-2024 03-31-2024 10-K
2 02-20-2024 12-31-2023 10-Q
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 06-29-2023 03-31-2023 10-K
6 02-14-2023 12-31-2022 10-Q
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 07-14-2022 03-31-2022 10-K
10 02-14-2022 12-31-2021 10-Q
11 11-04-2021 09-30-2021 10-Q
12 08-17-2021 06-30-2021 10-Q
13 06-22-2021 03-31-2021 10-K
14 02-16-2021 12-31-2020 10-Q
15 11-13-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 07-15-2020 03-31-2020 10-K
18 02-14-2020 12-31-2019 10-Q
19 11-14-2019 09-30-2019 10-Q
20 08-15-2019 06-30-2019 10-Q
21 07-16-2019 03-31-2019 10-K
22 02-19-2019 12-31-2018 10-Q
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 07-13-2018 03-31-2018 10-K
26 02-14-2018 12-31-2017 10-Q
27 11-14-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 03-30-2017 12-31-2016 10-K
30 11-18-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 12-21-2015 11-30-2015 10-Q
34 11-30-2015 08-31-2015 10-K
35 07-14-2015 05-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 biotricity-launches-instant-at-home-heart-health-screening-service-heartsecure

Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) company committed to disrupting the healthcare indu...

 biotricity-q4-2024-adj-eps-047-misses-036-estimate-sales-3200m-inline

Biotricity (NASDAQ:BTCY) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.36) ...

 biotricity-announces-high-demand-for-its-lbiotres-pro-a-3-channel-patch-like-ecg-biotres-pro-is-expected-to-raise-the-average-subscription-price-by-over-32-translating-to-revenue-increase-of-up-to-10-from-sales-to-existing-customers-throughout-2025

Biotres Pro Is Also Capturing The Attention Of New Customers. The Initial Production Run Of Biotres Pro Has Sold Out, With Cust...

 why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

 biotricity-unveils-that-improved-margins-resulted-from-latest-advancements-to-its-proprietary-cardiac-ai-cloud-platform-and-announces-plans-for-continued-expansion-of-its-cardiac-ai-cloud

Biotricity's AI automation engine has already proven to increase operational efficiency and support growth, evidenced by th...

 biotricity-q3-2024-adj-eps-012-beats-044-estimate-sales-297m-miss-300m-estimate

Biotricity (NASDAQ:BTCY) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.44) by...

 why-fluor-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

 earnings-scheduled-for-february-20-2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue...

 biotricitys-earnings-outlook
Biotricity's Earnings Outlook
02/19/2024 20:01:46